Publications by authors named "Hubert NueSSlein"

Claim this Profile
T
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial.
Koray Tascilar, Melanie Hagen, Arnd Kleyer, David Simon, Michaela Reiser, Hubert Nuesslein

Lancet Rheumatol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.
Camille P Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, Matthias Englbrecht, Axel J Hueber, Hubert Nuesslein

Ann Rheum Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.
Juergen Rech, Axel J Hueber, Stephanie Finzel, Matthias Englbrecht, Judith Haschka, Hubert Nuesslein

Ann Rheum Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
Judith Haschka, Matthias Englbrecht, Axel J Hueber, Bernhard Manger, Arnd Kleyer, Hubert Nuesslein

Ann Rheum Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis